http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100036718-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_142d981bd6c180968f769e0da8f620da |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-342 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B40-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2008-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e885ba076768e7789177a6a96f7687c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f46de327651410051d41fa01eb01595d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63064454d659fb2e8116621773a12cff |
| publicationDate | 2010-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100036718-A |
| titleOfInvention | A marker for diagnosing prostate cancer susceptibility using the RET gene and a method for predicting and determining prostate cancer susceptibility using the same |
| abstract | The present invention relates to a marker for diagnosing prostate cancer susceptibility using RETN gene and a method for predicting and determining prostate cancer susceptibility using the same. More specifically, a marker for diagnosing prostate cancer susceptibility based on polymorphism of RETN gene, prostate cancer susceptibility diagnostic kit using the same, micro A method of predicting and determining array and prostate cancer susceptibility. The prostate cancer susceptibility diagnostic marker of the present invention has the effect of diagnosing the degree of susceptibility to prostate cancer. Therefore, the marker of the present invention and its application method can be used for the purpose of predicting and determining susceptibility to prostate cancer.n n n n RETN, prostate cancer, susceptibility, diagnosis |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101336201-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101492710-B1 |
| priorityDate | 2008-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 170.